William P. Sheridan
2013
In 2013, William P. Sheridan earned a total compensation of $1.2M as Senior Vice President and Chief Medical Officer at BioCryst Pharmaceuticals, a 21% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $87,961 |
|---|---|
| Option Awards | $673,965 |
| Salary | $418,860 |
| Stock Awards | $24,140 |
| Other | $21,431 |
| Total | $1,226,357 |
Sheridan received $674K in option awards, accounting for 55% of the total pay in 2013.
Sheridan also received $88K in non-equity incentive plan, $418.9K in salary, $24.1K in stock awards and $21.4K in other compensation.
Rankings
In 2013, William P. Sheridan's compensation ranked 5,751st out of 12,286 executives tracked by ExecPay. In other words, Sheridan earned more than 53.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,751 out of 12,286 | 53rd |
Division Manufacturing | 2,002 out of 4,612 | 57th |
Major group Chemicals And Allied Products | 585 out of 1,462 | 60th |
Industry group Drugs | 418 out of 1,156 | 64th |
Industry Biological Products, Except Diagnostic Substances | 61 out of 196 | 69th |
Source: SEC filing on April 11, 2016.
Sheridan's colleagues
We found four more compensation records of executives who worked with William P. Sheridan at BioCryst Pharmaceuticals in 2013.